SCHEMBL1937435

SCHEMBL1937435

COc1cc(OC)c(Cl)c(-c2c(-c3ccccc3)nnc(C)c2-c2c(F)cc(F)cc2F)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MAPK1 P28482 1/20 0.36
RECQL P46063 1/20 0.36
ALDH1A1 P00352 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
NTSR1 P30989 2/20 0.34
GPR55 Q9Y2T6 2/20 0.34
LMNA P02545 2/20 0.34
RPS6KB1 P23443 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
PDE2A O00408 3/20 0.33
PDE10A Q9Y233 3/20 0.33
PDE6D O43924 1/20 0.33
PDE6A P16499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1937549 0.90 NPC1 (0.36) MAPTADORA2AADORA1SMN1; SMN2PDE2A
SCHEMBL1938749 0.82 ADORA2A (0.46) KDM4EL3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL1162736 0.81 ALDH1A1 (0.33) KDM4EALDH1A1PDE2APDE10APDE6D
SCHEMBL1937703 0.77 ADORA2A (0.48) KDM4EL3MBTL1ALDH1A1KMT2AMAPT
SCHEMBL1559111 0.77 NPC1 (0.37) L3MBTL1KMT2AMAPTSMN1; SMN2PDE2A
SCHEMBL1937723 0.73 ABL1 (0.38) MAPTADORA2AADORA1SMN1; SMN2PDE2A
SCHEMBL29184356 0.73 MEN1 (0.34) ALDH1A1KMT2AMEN1PDE2APDE10A
SCHEMBL30284776 0.73 MEN1 (0.34) ALDH1A1KMT2AMEN1PDE2APDE10A
SCHEMBL14324084 0.71 ALDH1A1 (0.37) KDM4EALDH1A1KMT2AMAPTMEN1
SCHEMBL13165373 0.71 MAOB (0.45) KDM4EL3MBTL1KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2330891-A1 FUNGICIDAL PYRIDAZINES E. I. du Pont de Nemours and Company (US) 2011-06-15 EP claimed
US-20110136762-A1 FUNGICIDAL PYRIDAZINES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-09 US claimed
WO-2010036553-A1 FUNGICIDAL PYRIDAZINES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-04-01 WO claimed
EP-2330891-A1 FUNGICIDAL PYRIDAZINES E. I. du Pont de Nemours and Company (US) 2011-06-15 EP disclosed
US-20110136762-A1 FUNGICIDAL PYRIDAZINES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-06-09 US disclosed
WO-2010036553-A1 FUNGICIDAL PYRIDAZINES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136762-A1 FUNGICIDAL PYRIDAZINES PRDX1, PNPO, PRXL2A KDM4E 1409/4885L3MBTL1 1890/4885MAPK1 876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.